The covid-19 pandemic demonstrates conclusively that a top priority for society, now and in the future, is to be able to respond quickly to diseases with effective treatments.
Major digital and computing advancements — including machine learning / artificial intelligence, extreme-scale computer simulations, and big-data analytics — have revolutionized the pharmaceutical industry, and by effectively harnessing these tools in a broader capacity for drug discovery, we have an excellent opportunity to reduce the time-to-patient and to lower the investment risk.
Deep-tech project LIGATE develops and validates a portable and tunable drug discovery solution in HPC systems up to exascale level.